InVivo Therapeutics Holdings Corp. Gains 61.28%
Mon, Dec 30, 2019 at 05:30 PM
InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ) shot up at $0.29, representing a gain of 61.3%. On Fri 27 Dec 19, NVIV:NASDAQ touched a New 2-Week High of $0.18. From Fri 06 Dec 19, the stock recorded 28.57% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ)
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.
Top 10 Gainers:
- Savara Inc. (SVRA:NASDAQ), 183.82%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 61.28%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 58.18%
- NIO Inc. (NIO:NYSE), 53.72%
- Ocugen, Inc. (OCGN:NASDAQ), 44.75%
- Ra Medical Systems, Inc. (RMED:NYSE), 38.52%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.94%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 36.27%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 32.28%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 31.04%